Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT06624319
Starting soon Not applicable

Two Doses of Dexmedetomidine as Adjuvent to Bupivacaine in Tap Block

NCT06624319 · tracked via the Priya Life Science Egypt tracker
Sponsor
Assiut University
Phase
Not applicable
Started
2025-01
Last updated
2024-10-03

Condition(s) studied

Post Operative Pain

Investigational drug(s) / intervention(s)

Dexmedetomidine as adjuvent to bupvacaine in tap block

Dexmedetomidine as adjuvent to bupvacaine in tap block: The analgesic effect of Two different doses of dexmedetomidine as adjuvent to bupivacaine in tap block

Study summary

The aim of this study to determine the optimal dose of dexmedetomidine as an adjuvant to bupivacaine in U.S guided TAP block for preemptive analgesia In patients undergoing lower abdominal cancer surgeries.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * age from 18 to 65 years old * lower abdominal cancer surgery Exclusion Criteria: * patient refusal * the local anesthetic allergy * coagulopathy * local infection at the procedure site * psychic patients * patient on chronic opioid use

Primary outcome measure(s)

  • Total morphine consumption during the first 24 hours postoperatively — First 24 hours postoperative
    Morphine consumption during the First 24 hours postoperative

Trial sites (1)

FacilityCityRegionStatus
South egypt cancer institute,Assiut University Asyut Egypt

More Assiut University trials in Egypt

Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder Recruiting
The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion Starting soon
Maternal Iron Deficiency and/or Iron Deficiency Anemia to Neonatal Hemoglobin Concentration and Iron Stores Starting soon
Real-Time (TRUS) Guidance in Endoscopic Treatment of BPH Starting soon
Intraoperative Lidocaine Infusion Starting soon

Other trials for the same condition

The Analgesic Efficacy of M-TAPA for Laparoscopic Abdominal Surgery in Children Recruiting
Comparison Between Two Instrumentation Techniques on Postoperative Pain and Level of Neuropeptides Recruiting
Analgesic Efficacy of Different Nerve Blocks in Postoperative Cesarean Section Recruiting
Recycling of Three Pressable Ceramics With Different Weight Percentage Active, not recruiting
Effect of NeoSEALER FLO and AH Plus Resin Sealer on Postoperative Pain and Healing of Periapical Lesions Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06624319 on ClinicalTrials.gov ↗ ← All trials in Egypt